Algert Global’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.7M	Buy	928,568 +480	+0.1%	+$10.4K	0.33%	49
2025 Q4	$19.5M	Sell	928,088 -2,678	-0.3%	-$46.7K	0.3%	58
2025 Q3	$14.3M	Sell	930,766 -90,514	-9%	-$1.18M	0.24%	96
2025 Q2	$9.56M	Buy	1,021,280 +136,680	+15%	+$1.5M	0.2%	140
2025 Q1	$10.9M	Buy	884,600 +98,968	+13%	+$1.4M	0.27%	82
2024 Q4	$10.4M	Buy	785,632 +310,634	+65%	+$5.32M	0.24%	99
2024 Q3	$9.14M	Buy	474,998 +42,870	+10%	+$886K	0.25%	95
2024 Q2	$8.87M	Buy	432,128 +6,455	+2%	+$135K	0.3%	61
2024 Q1	$10.1M	Sell	425,673 -102,484	-19%	-$2.29M	0.4%	35
2023 Q4	$11.4M	Buy	528,157 +71,938	+16%	+$1.11M	0.46%	13
2023 Q3	$6.62M	Buy	456,219 +202,588	+80%	+$3.83M	0.31%	67
2023 Q2	$5.31M	Buy	253,631 +167,660	+195%	+$3.49M	0.23%	104
2023 Q1	$1.82M	Buy	85,971 +8,191	+11%	+$204K	0.09%	381
2022 Q4	$1.98M	Buy	77,780 +28,880	+59%	+$674K	0.11%	300
2022 Q3	$1.18M	Sell	48,900 -5,814	-11%	-$130K	0.07%	471
2022 Q2	$1.05M	Buy	54,714 +13,180	+32%	+$220K	0.08%	448
2022 Q1	$722K	Buy	41,534 +9,948	+31%	+$168K	0.05%	666
2021 Q4	$691K	Buy	+31,586	New	+$584K	0.09%	420
2021 Q2	–	Sell	-9,550	Closed	-$214K	–	520
2021 Q1	$214K	Sell	9,550 -18,020	-65%	-$407K	0.07%	366
2020 Q4	$613K	Buy	27,570 +8,440	+44%	+$175K	0.17%	191
2020 Q3	$282K	Buy	19,130 +8,350	+77%	+$127K	0.09%	268
2020 Q2	$160K	Sell	10,780 -11,800	-52%	-$180K	0.05%	346
2020 Q1	$248K	Sell	22,580 -3,000	-12%	-$28.2K	0.1%	278
2019 Q4	$225K	Buy	25,580 +8,110	+46%	+$59.6K	0.07%	300
2019 Q3	$131K	Buy	17,470 +1,600	+10%	+$14.6K	0.05%	308
2019 Q2	$148K	Buy	+15,870	New	+$116K	0.05%	302
2018 Q3	–	Sell	-73,499	Closed	-$516K	–	382
2018 Q2	$516K	Buy	+73,499	New	+$721K	0.11%	241